P-098 p53 protein expression predicts outcome and cytogenetic response in patients with low-/INT-1-risk myelodysplastic syndromes treated with lenalidomide von Saft, L, Karimi, M, Ghaderi, M, Matolscy, A, Fenaux, P, Mufti, G, Giagounidis, A, Selleslag, D, Muus, P, Sanz, G, Mittelman, M, Bowen, D, Porwit, A, Fu, T, Backstrom, J, MacBeth, K, Hellström-Lindberg, E

Volltext